SOX2 and central nervous system cancer: Sox2, commonly expressed by glioma cells and stem cells of the embryonic and adult brain [23] maintains proliferative potential of neural precursor cells, glioma-initiating cells and drives oncogenesis- associated aggressive tumor phenotype.